37 results on '"Yzet, Clara"'
Search Results
2. Defining Endoscopic Remission in Crohn’s Disease: MM-SES-CD and SES-CD Thresholds Associated with Low Risk of Disease Progression
3. Endoscopic submucosal dissection of appendicular lesions is feasible and safe: a retrospective multicenter study (with video)
4. Is there concordance between the Cellvizio system and pathology in determining microscopic inflammation at the ileal resection margins in Crohn's ileal disease? The CELLVICROHN study
5. Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Diseases: the REMSWITCH Study
6. ENDOSCOPIC SUBMUCOSAL DISSECTION OR FULL-THICKNESS RESECTION DEVICE TO TREAT RECURRENT OR RESIDUAL NEOPLASIA AFTER ENDOSCOPIC RESECTION: A MULTICENTER HISTORICAL COHORT STUDY
7. 1142 TRANSMURAL HEALING IS NOT ASSOCIATED WITH LESS DISABILITY THAN COMPLETE ENDOSCOPIC MUCOSAL HEALING: A PROSPECTIVE STUDY IN A PATIENT WITH CROHN'S DISEASE
8. Positive margins and plexitis increase the risk of recurrence after ileocecal resection: A systematic review and meta-analysis
9. 718: EVOLUTION OF CLINICAL AND PHARMACOLOGICAL PARAMETERS AFTER SWITCHING FROM INTRA-VENOUS TO SUBCUTANEOUS INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE : THE REMSWITCH STUDY
10. Complete endoscopic healing is associated with lower disability than partial endoscopic healing in Crohn's disease: A prospective multicenter study
11. Endoscopic balloon dilation of colorectal strictures complicating Crohn’s disease: a multicenter study
12. Positive histologic margins is a risk factor of recurrence after ileocaecal resection in Crohn’s disease
13. Reply
14. No Benefit of Concomitant Immunomodulator Therapy on Efficacy of Biologics That Are Not Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases: A Meta-analysis
15. Reply
16. Inflammatory bowel disease symptoms at the time of anal fistula lead to the diagnosis of Crohn's disease
17. Complete Endoscopic Healing Associated With Better Outcomes Than Partial Endoscopic Healing in Patients With Crohn’s Disease
18. Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease
19. Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial
20. Su1912 CDEIS SCORE OF 2 IS OPTIMAL CUT-OFF ASSOCIATED WITH LOWER RISK OF DISEASE PROGRESSION IN EARLY CROHN'S DISEASE: DATA FROM THE CALM STUDY
21. Stopping Mesalamine Therapy in Patients With Crohn’s Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes
22. Sa1788 LOW LEVELS OF VITAMIN D AND OSTEOPENIA ARE COMMON IN ULCERATIVE COLITIS PATIENTS AFTER TOTAL PROCTOCOLECTOMY WITH ILEAL POUCH ANAL ANASTOMOSIS
23. Mo1826 – Hold the Mayo, are Endoscopists Taking Histology in Stride? Discordance Among Endoscopic Activity and Histologic Findings in Ulcerative Colitis
24. Mo1899 – Prognostic Factors for Long-Term Adalimumab Treatment in Crohn’s Disease : A Multicenter Experience
25. 110 – Stopping 5-Aminosalicylates in Crohn's Disease Patients Starting Biologic Therapy Does Not Increase the Risk of Adverse Clinical Outcomes: Analysis of Two Nationwide Population-Based Cohorts
26. 705 – Pre-Operative Biologics Significantly Reduce Post-Operative Leaks After Staged Restorative Proctocolectomy
27. Mo1806 – Endoscopic Pouch Activity in Asymptomatic Patients with an Ileal Pouch Anal Anastomosis is Associated with an Increased Risk of Future Pouchitis
28. Tu2043 – Efficacy and Safety of Percutaneous Rendez-Vous Technique After Failed Ercp for Malignant Biliary Obstruction
29. Sa1813 – Cuffitis is Associated with a Significant Risk of Ileal Pouch Anal Anastomosis Failure
30. Mo1844 – Long-Term Fate of the Excluded Rectum in Crohn’s Disease
31. Mo1942 – Clostridium Difficile of the Ileal Pouch Anal Anastomosis – Incidence, Risk Factors, and Outcomes
32. Sa1812 – Endoscopic and Deep Remission At 1 Year Prevents Disease Progression in Early Crohn's Disease: Long-Term Data from Calm
33. Premedication as primary prophylaxis does not influence the risk of acute infliximab infusion reactions in immune-mediated inflammatory diseases: A systematic review and meta-analysis
34. Su1891 - Long-Term Natural History of Microscopic Colitis: A Population-Based Study
35. Tu1714 - What is the Risk of Crohn's Disease in Patients with Anal Fistula Surgery?
36. Evaluation of the Diagnostic and Prognostic Value of Procalcitonin in Acute Colitis
37. What is the Best definition of Mucosal Healing in Crohn Disease?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.